David A. Siegel Zoetis Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Zoetis Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 33,700 shares of ZTS stock, worth $5.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,700

Previous 80,400 58.08%

Holding current value

$5.55 Million

Previous $13.9 Million 52.76%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $8.06 Million - $9.18 Million	-46,700 Reduced 58.08%	33,700 $6.58 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $7.22 Million - $8.87 Million	49,600 Added 161.04%	80,400 $13.9 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $3.61 Million - $4.36 Million	21,800 Added 242.22%	30,800 $5.21 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $1.42 Million - $1.88 Million	-9,400 Reduced 51.09%	9,000 $1.78 Million
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $3.38 Million - $3.89 Million	-20,200 Reduced 52.33%	18,400 $3.2 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $2.08 Million - $2.4 Million	12,900 Added 50.19%	38,600 $6.65 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $59.3 Million - $71.4 Million	-407,700 Reduced 94.07%	25,700 $4.28 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $45.6 Million - $54.7 Million	-347,500 Reduced 44.5%	433,400 $63.5 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $54.3 Million - $66.9 Million	-366,300 Reduced 31.93%	780,900 $116 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $43.1 Million - $55.3 Million	276,400 Added 31.74%	1,147,200 $197 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $121 Million - $156 Million	667,100 Added 327.49%	870,800 $164 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $4.9 Million - $6.25 Million	-25,300 Reduced 11.05%	203,700 $49.7 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $30.8 Million - $34.1 Million	162,600 Added 244.88%	229,000 $44.5 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $57.3 Million - $69.1 Million	-367,700 Reduced 84.7%	66,400 $12.4 Million
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $50.5 Million - $59.4 Million	350,496 Added 419.23%	434,100 $68.4 Million
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $47.5 Million - $52.8 Million	-302,600 Reduced 78.35%	83,604 $13.8 Million
Q3 2020 Nov 16, 2020	SELL	$137.1 - $165.37 $38.3 Million - $46.2 Million	-279,407 Reduced 41.98%	386,204 $63.9 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $21.8 Million - $27.8 Million	-195,000 Reduced 22.66%	665,611 $91.2 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $13.3 Million - $20.9 Million	-143,900 Reduced 14.33%	860,611 $101 Million
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $1.36 Million - $1.56 Million	-11,700 Reduced 1.15%	1,004,511 $133 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $30.2 Million - $34.5 Million	-268,300 Reduced 20.89%	1,016,211 $127 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $39.7 Million - $46.3 Million	-404,900 Reduced 23.97%	1,284,511 $146 Million
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $44.1 Million - $54.4 Million	540,300 Added 47.02%	1,689,411 $170 Million
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $82.4 Million - $99 Million	1,039,400 Added 947.4%	1,149,111 $98.3 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $7.53 Million - $8.41 Million	90,200 Added 462.3%	109,711 $10 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $4.82 Million - $5.38 Million	-60,300 Reduced 75.55%	19,511 $1.66 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $5.71 Million - $6.76 Million	79,811 New	79,811 $6.67 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account